Regulation of allergy by Fc receptors

Current Opinion in Immunology

Volumn 17, Issue 6, 2005, Pages 662-669

  Bruhns, Pierre ^a   Frémont, Sophie ^a,b   Daëron, Marc ^a  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; FEL D1 PEPTIDE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; LAT PROTEIN; OMALIZUMAB; PEPTIDE DERIVATIVE; PROTEIN KINASE LYN; RECEPTOR SUBTYPE; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ALLERGIC RHINITIS; ALLERGY; BASOPHIL; CAPPING PHENOMENON; CELL ACTIVATION; CELLULAR DISTRIBUTION; DNA POLYMORPHISM; DRUG EFFICACY; DRUG SAFETY; DRUG TARGETING; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; IMMUNOPATHOGENESIS; IMMUNOREGULATION; MAST CELL; NONHUMAN; PEANUT ALLERGY; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BASOPHILS; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; MAST CELLS; MICE; RECEPTORS, FC; RECEPTORS, IGE; SIGNAL TRANSDUCTION;

EID: 27144471397     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2005.09.012     Document Type: Review

References (50)

1. B. Heyman IgE-mediated enhancement of antibody responses: the beneficial function of IgE? Allergy 57 2002 577 585
2. G. Lewis, E. Rapsomaniki, T. Bouriez, T. Crockford, H. Ferry, R. Rigby, T. Vyse, T. Lambe, and R. Cornall Hyper IgE in New Zealand black mice due to a dominant-negative CD23 mutation Immunogenetics 56 2004 564 571
3. G. Montagnac, L.C. Yu, C. Bevilacqua, M. Heyman, D.H. Conrad, M.H. Perdue, and A. Benmerah Differential role for CD23 splice forms in apical to basolateral transcytosis of IgE/allergen complexes Traffic 6 2005 230 242
4. S.R. Gillespie, R.R. DeMartino, J. Zhu, H.J. Chong, C. Ramirez, C.P. Shelburne, L.A. Bouton, D.P. Bailey, A. Gharse, and P. Mirmonsef IL-10 inhibits Fc epsilon RI expression in mouse mast cells J Immunol 172 2004 3181 3188
5. E. Donnadieu, M.H. Jouvin, S. Rana, M.F. Moffatt, E.H. Mockford, W.O. Cookson, and J.P. Kinet Competing functions encoded in the allergy-associated F(c)epsilonRIbeta gene Immunity 18 2003 665 674
6. E. Fiebiger, D. Tortorella, M.H. Jouvin, J.P. Kinet, and H.L. Ploegh Cotranslational endoplasmic reticulum assembly of Fc{varepsilon}RI controls the formation of functional IgE-binding receptors J Exp Med 201 2005 267 277
7. L. Rigoli, C. Di Bella, V. Procopio, G. Barberio, I. Barberi, L. Caminiti, S. La Grutta, S. Briuglia, C.D. Salpietro, and G.B. Pajno Molecular analysis of sequence variants in the Fcepsilon receptor I beta gene and IL-4 gene promoter in Italian atopic families Allergy 59 2004 213 218
8. X. Zhang, W. Zhang, D. Qiu, A. Sandford, and W.C. Tan The E237G polymorphism of the high-affinity IgE receptor beta chain and asthma Ann Allergy Asthma Immunol 93 2004 499 503
9. C. Nishiyama, Y. Akizawa, M. Nishiyama, T. Tokura, H. Kawada, K. Mitsuishi, M. Hasegawa, T. Ito, N. Nakano, and A. Okamoto Polymorphisms in the Fc epsilon RI beta promoter region affecting transcription activity: a possible promoter-dependent mechanism for association between Fc epsilon RI beta and atopy J Immunol 173 2004 6458 6464 The controversy involving a possible SNP in the coding region of the FcRβ gene, which was previously linked to allergic symptoms and FcεRI expression level, and the finding that the resulting mutation does not by itself modulate this expression, is solved in this work. Indeed, the authors describe additional SNPs in the FcRβ gene promoter region, linked to the previously described SNP, leading to enhanced promoter activity and thereby enhanced FcεRI expression in atopic individuals.
10. E. Donnadieu, W.O. Cookson, M.H. Jouvin, and J.P. Kinet Allergy-associated polymorphisms of the Fc epsilon RI beta subunit do not impact its two amplification functions J Immunol 165 2000 3917 3922
11. Y. Furumoto, S. Hiraoka, K. Kawamoto, S. Masaki, T. Kitamura, K. Okumura, and C. Ra Polymorphisms in FcepsilonRI beta chain do not affect IgE-mediated mast cell activation Biochem Biophys Res Commun 273 2000 765 771
12. T.A. Borkowski, M.H. Jouvin, S.Y. Lin, and J.P. Kinet Minimal requirements for IgE-mediated regulation of surface Fc epsilon RI J Immunol 167 2001 1290 1296
13. K. Asai, J. Kitaura, Y. Kawakami, N. Yamagata, M. Tsai, D.P. Carbone, F.T. Liu, S.J. Galli, and T. Kawakami Regulation of mast cell survival by IgE Immunity 14 2001 791 800
14. T. Kawakami, and S.J. Galli Regulation of mast-cell and basophil function and survival by IgE Nat Rev Immunol 2 2002 773 786
15. J. Kalesnikoff, M. Huber, V. Lam, J.E. Damen, J. Zhang, R.P. Siraganian, and G. Krystal Monomeric IgE stimulates signalling pathways in mast cells that lead to cytokine production and cell survival Immunity 14 2001 801 811
16. M. Kohno, S. Yamasaki, V.L. Tybulewicz, and T. Saito Rapid and large amount of autocrine IL-3 production is responsible for mast cell survival by IgE in the absence of antigen Blood 105 2005 2059 2065
17. J. Kitaura, J. Song, M. Tsai, K. Asai, M. Maeda-Yamamoto, A. Mocsai, Y. Kawakami, F.T. Liu, C.A. Lowell, and B.G. Barisas Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcepsilonRI Proc Natl Acad Sci USA 100 2003 12911 12916
18. J. Kitaura, W. Xiao, M. Maeda-Yamamoto, Y. Kawakami, C.A. Lowell, and T. Kawakami Early divergence of Fc epsilon receptor I signals for receptor up-regulation and internalization from degranulation, cytokine production, and survival J Immunol 173 2004 4317 4323
19. R. Schweitzer-Stenner, and I. Pecht Cutting Edge: Death of a Dogma or Enforcing the Artificial: Monomeric IgE Binding May Initiate Mast Cell Response by Inducing Its Receptor Aggregation J Immunol 174 2005 4461 4464
20. C. Gonzalez-Espinosa, S. Odom, A. Olivera, J.P. Hobson, M.E. Martinez, A. Oliveira-Dos-Santos, L. Barra, S. Spiegel, J.M. Penninger, and J. Rivera Preferential signalling and induction of allergy-promoting lymphokines upon weak stimulation of the high affinity IgE receptor on mast cells J Exp Med 197 2003 1453 1465
21. S. Yamasaki, E. Ishikawa, M. Kohno, and T. Saito The quantity and duration of FcRgamma signals determine mast cell degranulation and survival Blood 103 2004 3093 3101
22. K. Gimborn, E. Lessmann, S. Kuppig, G. Krystal, and M. Huber SHIP down-regulates FcepsilonR1-induced degranulation at supraoptimal IgE or antigen levels J Immunol 174 2005 507 516
23. J.M. Oliver, J.R. Pfeiffer, Z. Surviladze, S.L. Steinberg, K. Leiderman, M.L. Sanders, C. Wofsy, J. Zhang, H. Fan, and N. Andrews Membrane receptor mapping: the membrane topography of Fc(epsilon)RI signalling Subcell Biochem 37 2004 3 34
24. C. Torigoe, J. Song, B.G. Barisas, and H. Metzger The influence of actin microfilaments on signalling by the receptor with high-affinity for IgE Mol Immunol 41 2004 817 829
25. H. Tolarova, L. Draberova, P. Heneberg, and P. Draber Involvement of filamentous actin in setting the threshold for degranulation in mast cells Eur J Immunol 34 2004 1627 1636
26. A. Kettner, L. Kumar, I.M. Anton, Y. Sasahara, M. de la Fuente, V.I. Pivniouk, H. Falet, J.H. Hartwig, and R.S. Geha WIP regulates signalling via the high affinity receptor for immunoglobulin E in mast cells J Exp Med 199 2004 357 368
27. Y. Furumoto, S. Nunomura, T. Terada, J. Rivera, and C. Ra The FcepsilonRIbeta immunoreceptor tyrosine-based activation motif exerts inhibitory control on MAPK and IkappaB kinase phosphorylation and mast cell cytokine production J Biol Chem 279 2004 49177 49187
28. V. Hernandez-Hansen, A.J. Smith, Z. Surviladze, A. Chigaev, T. Mazel, J. Kalesnikoff, C.A. Lowell, G. Krystal, L.A. Sklar, and B.S. Wilson Dysregulated FcepsilonRI signalling and altered Fyn and SHIP activities in Lyn-deficient mast cells J Immunol 173 2004 100 112
29. S. Odom, G. Gomez, M. Kovarova, Y. Furumoto, J.J. Ryan, H.V. Wright, C. Gonzalez-Espinosa, M.L. Hibbs, K.W. Harder, and J. Rivera Negative regulation of immunoglobulin E-dependent allergic responses by Lyn kinase J Exp Med 199 2004 1491 1502 This work dissects the mechanisms responsible for the allergic-like phenotype of Lyn-deficient mice. The study shows how this src kinase phosphorylates an adaptor that recruits a kinase which inactivates src kinases by phosphorylating a regulatory tyrosine of these enzymes. It also shows how, by reducing IL-4 signalling in B cells, Lyn prevents high titers of IgE from being synthesized and, as a consequence, controls mast cell numbers and FcεRI expression.
30. S-I. Saitoh, S. Odom, G. Gomez, C.L. Sommers, H.A. Young, J. Rivera, and L.E. Samelson The Four Distal Tyrosines Are Required for LAT-dependent Signalling in FcεRI-mediated Mast Cell Activation J Exp Med 198 2003 831 843
31. E. Aguado, S. Richelme, S. Nunez-Cruz, A. Miazek, A.M. Mura, M. Richelme, X.J. Guo, D. Sainty, H.T. He, and B. Malissen Induction of T helper type 2 immunity by a point mutation in the LAT adaptor Science 296 2002 2036 2040
32. S. Nuñez-Cruz, E. Aguado, S. Richelme, B. Chetaille, A-M. Mura, M. Richelme, L. Pouyet, E. Jouvin-Marche, L. Xerri, and B. Malissen LAT regulates γδ T cell homeostasis and differentiation Nat Immunol 4 2003 999 1008
33. O. Malbec, M. Malissen, I. Isnardi, R. Lesourne, A.M. Mura, W.H. Fridman, B. Malissen, and M. Daëron Linker for activation of T cells integrates positive and negative signalling in mast cells J Immunol 173 2004 5086 5094
34. P. Volna, P. Lebduska, L. Draberova, S. Simova, P. Heneberg, M. Boubelik, V. Bugajev, B. Malissen, B.S. Wilson, and V. Horejsi Negative regulation of mast cell signalling and function by the adaptor LAB/NTAL J Exp Med 200 2004 1001 1013
35. M. Zhu, Y. Liu, S. Koonpaew, O. Granillo, and W. Zhang Positive and negative regulation of FcepsilonRI-mediated signalling by the adaptor protein LAB/NTAL J Exp Med 200 2004 991 1000
36. C. Tkaczyk, V. Horejsi, S. Iwaki, P. Draber, L.E. Samelson, A.B. Satterthwaite, D.H. Nahm, D.D. Metcalfe, and A.M. Gilfillan NTAL phosphorylation is a pivotal link between the signalling cascades leading to human mast cell degranulation following Kit activation and Fc epsilon RI aggregation Blood 104 2004 207 214
37. H.M. Cherwinski, C.A. Murphy, B.L. Joyce, M.E. Bigler, Y.S. Song, S.M. Zurawski, M.M. Moshrefi, D.M. Gorman, K.L. Miller, and S. Zhang The CD200 receptor is a novel and potent regulator of murine and human mast cell function J Immunol 174 2005 1348 1356
38. S. Kraft, T. Fleming, J.M. Billingsley, S.Y. Lin, M.H. Jouvin, P. Storz, and J.P. Kinet Anti-CD63 antibodies suppress IgE-dependent allergic reactions in vitro and in vivo J Exp Med 201 2005 385 396
39. B. Pasquier, P. Launay, Y. Kanamaru, I.C. Moura, S. Pfirsch, C. Ruffie, D. Henin, M. Benhamou, M. Pretolani, and U. Blank Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM Immunity 22 2005 31 42 An ITAM-bearing receptor that activates cells upon aggregation by multivalent ligands was found to inhibit cell activation induced by other receptors upon ligation by monovalent ligands. Monovalent binding induced a weak phosphorylation of ITAMs, which recruited the tyrosine phosphatase SHP-1. The significance of this finding will increase if it is reproduced in more physiological models.
40. Daëron M, Lesourne R: Negative signalling in Fc Receptor complexes. Adv Immunol 2005, in press.
41. R. Lesourne, W.H. Fridman, and M. Daëron Dynamic interactions of Fc gamma receptor IIB with filamin-bound SHIP1 amplify filamentous actin-dependent negative regulation of Fc epsilon receptor I signalling J Immunol 174 2005 1365 1373
42. T. Watanabe, M. Okano, H. Hattori, T. Yoshino, N. Ohno, N. Ohta, Y. Sugata, Y. Orita, T. Takai, and K. Nishizaki Roles of FcgammaRIIB in nasal eosinophilia and IgE production in murine allergic rhinitis Am J Respir Crit Care Med 169 2004 105 112
43. J.N. Samsom, L.A. van Berkel, J.M. van Helvoort, W.W. Unger, W. Jansen, T. Thepen, R.E. Mebius, S.S. Verbeek, and G. Kraal Fc{gamma}RIIB Regulates Nasal and Oral Tolerance: A Role for Dendritic Cells J Immunol 174 2005 5279 5287
44. M.R. Woolhiser, K. Brockow, and D.D. Metcalfe Activation of human mast cells by aggregated IgG through FcgammaRI: additive effects of C3a Clin Immunol 110 2004 172 180
45. R. Djukanovic, S.J. Wilson, M. Kraft, N.N. Jarjour, M. Steel, K.F. Chung, W. Bao, A. Fowler-Taylor, J. Matthews, and W.W. Busse Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma Am J Respir Crit Care Med 170 2004 583 593
46. D.Y. Leung, H.A. Sampson, J.W. Yunginger, A.W. Burks Jr., L.C. Schneider, C.H. Wortel, F.M. Davis, J.D. Hyun, and W.R. Shanahan Jr. Effect of anti-IgE therapy in patients with peanut allergy N Engl J Med 348 2003 986 993
47. R. Belostotsky, and H. Lorberboum-Galski Utilizing Fcepsilon-Bak chimeric protein for studying IgE-FcepsilonRI interactions Clin Immunol 110 2004 89 99
48. D. Zhu, C.L. Kepley, M. Zhang, K. Zhang, and A. Saxon A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon RI-mediated degranulation Nat Med 8 2002 518 521
49. 1 was shown to inhibit IgE-induced reactions in vitro and in vivo. The mechanism proposed for inhibition may not be prominent but, whatever the mechanism, this innovative molecule seemed quite efficient.
50. S.W. Tam, S. Demissie, D. Thomas, and M. Daëron A bispecific antibody against human IgE and human FcgammaRII that inhibits antigen-induced histamine release by human mast cells and basophils Allergy 59 2004 772 780